YILMAZ, S. Et Al. 2017. Could serum S100B be a predictor of neuro-nal damage and poor clinical outcomes associated with the use of synthetic cannabinoids?. XI. European Congress on Emergency Medicine .

YILMAZ, S., KARAKAYALI, O., KALE, E., & Akdoğan, A., (2017). Could serum S100B be a predictor of neuro-nal damage and poor clinical outcomes associated with the use of synthetic cannabinoids? . XI. European Congress on Emergency Medicine

YILMAZ, SERKAN Et Al. "Could serum S100B be a predictor of neuro-nal damage and poor clinical outcomes associated with the use of synthetic cannabinoids?," XI. European Congress on Emergency Medicine, 2017

YILMAZ, SERKAN Et Al. "Could serum S100B be a predictor of neuro-nal damage and poor clinical outcomes associated with the use of synthetic cannabinoids?." XI. European Congress on Emergency Medicine , 2017

YILMAZ, S. Et Al. (2017) . "Could serum S100B be a predictor of neuro-nal damage and poor clinical outcomes associated with the use of synthetic cannabinoids?." XI. European Congress on Emergency Medicine .

@conferencepaper{conferencepaper, author={SERKAN YILMAZ Et Al. }, title={Could serum S100B be a predictor of neuro-nal damage and poor clinical outcomes associated with the use of synthetic cannabinoids?}, congress name={XI. European Congress on Emergency Medicine}, city={}, country={}, year={2017}}